DEFSEC Q3 Revenue Up 92%, BLISS™ Passes U.S. Army Testing
DFSC sits 28% above its 52-week low of $1.16.
Summary
DEFSEC's Q3 revenue jumped 92% to C$2.72M and BLISS™ passed U.S. Army testing, but the company still lost C$1.94M on an adjusted EBITDA basis and faces going concern and delisting risks.
Key Events · Earnings and Guidance · DFSC
-
Q3 Revenue Up 92%
Revenue reached C$2.72 million, up from C$1.42 million in Q3 FY2025, driven by 121% growth in digitization services on government programs.
-
Gross Margin Improves
Gross margin expanded to 33.1% from 28.2%, with gross margin dollars up 126% to C$901.7 thousand.
-
BLISS™ Passes U.S. Army Testing
Test and evaluation of BLISS™ completed at a U.S. Army test center, and the company was invited to an additional Army-hosted evaluation in late August 2026.
-
Adjusted EBITDA Loss
Adjusted EBITDA loss widened to C$1.94 million from C$1.49 million, reflecting higher operating expenses of C$3.46 million.
Analysis · DFSC · Technology
A 92% year-over-year revenue jump to C$2.72 million and a gross margin expansion to 33.1% highlight DEFSEC's strong Q3 performance. The company also completed U.S. Army test and evaluation of its BLISS™ laser detection system and received an invitation to an additional Army-hosted evaluation in late August 2026. Yet profitability remains elusive, with an adjusted EBITDA loss of C$1.94 million, and the company faces a going concern warning and Nasdaq delisting notice disclosed in its prior 6-K on August 12, 2026. While the BLISS™ milestones validate the technology roadmap, the financial position remains precarious.
At the time of this filing, DFSC was trading at $1.48 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $1.16 to $6.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.